James Hunt

955 total citations
17 papers, 662 citations indexed

About

James Hunt is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, James Hunt has authored 17 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in James Hunt's work include Mast cells and histamine (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and CAR-T cell therapy research (3 papers). James Hunt is often cited by papers focused on Mast cells and histamine (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and CAR-T cell therapy research (3 papers). James Hunt collaborates with scholars based in United Kingdom, United States and France. James Hunt's co-authors include Andrew J. Beavil, Hannah J. Gould, Brian J. Sutton, Rebecca L. Beavil, Natalie McCloskey, Enrico Girardi, Sophia N. Karagiannis, Simon Ameer‐Beg, David J. Fear and Maddy Parsons and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

James Hunt

16 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Hunt United Kingdom 12 317 277 229 121 119 17 662
Paul J. Jansen United States 10 800 2.5× 190 0.7× 337 1.5× 109 0.9× 71 0.6× 11 1.1k
Hyewon Phee United States 17 451 1.4× 99 0.4× 439 1.9× 149 1.2× 112 0.9× 32 866
So Ohta Japan 14 244 0.8× 259 0.9× 295 1.3× 168 1.4× 56 0.5× 18 600
A Nilson United States 17 518 1.6× 221 0.8× 261 1.1× 117 1.0× 80 0.7× 23 785
Mara Dottore Australia 18 730 2.3× 139 0.5× 320 1.4× 380 3.1× 105 0.9× 23 1.2k
Makoto Haino Japan 11 326 1.0× 242 0.9× 302 1.3× 91 0.8× 72 0.6× 15 709
Renaud Lesourne France 15 750 2.4× 148 0.5× 341 1.5× 270 2.2× 53 0.4× 27 1.0k
E. Kilchherr Switzerland 14 398 1.3× 213 0.8× 166 0.7× 40 0.3× 162 1.4× 20 748
Chikao Morimoto United States 13 363 1.1× 130 0.5× 190 0.8× 156 1.3× 251 2.1× 14 721
Alain Vallé France 8 941 3.0× 300 1.1× 289 1.3× 153 1.3× 156 1.3× 8 1.2k

Countries citing papers authored by James Hunt

Since Specialization
Citations

This map shows the geographic impact of James Hunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Hunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Hunt more than expected).

Fields of papers citing papers by James Hunt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Hunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Hunt. The network helps show where James Hunt may publish in the future.

Co-authorship network of co-authors of James Hunt

This figure shows the co-authorship network connecting the top 25 collaborators of James Hunt. A scholar is included among the top collaborators of James Hunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Hunt. James Hunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Taylor, Jonathan D., Sergio Martínez Cuesta, Fiona Pachl, et al.. (2024). Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes. Communications Biology. 7(1). 1179–1179. 11 indexed citations
2.
Xu, Linda, Ryan Gilbreth, Manuel Baca, et al.. (2023). Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach. Journal of Biological Chemistry. 299(12). 105381–105381. 4 indexed citations
3.
Fletcher, Alice, Dean Clift, Sergio Martínez Cuesta, et al.. (2023). A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation. Nature Communications. 14(1). 7093–7093. 23 indexed citations
5.
Morgan, C., Ian L. Dale, Andrew P. Thomas, James Hunt, & Jason W. Chin. (2021). Selective CRAF Inhibition Elicits Transactivation. Journal of the American Chemical Society. 143(12). 4600–4606. 18 indexed citations
6.
Dix, Carly I., Christopher J. Stubbs, Eileen McCall, et al.. (2019). Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies. Modern Pathology. 33(4). 518–530. 58 indexed citations
7.
Grünewald, Jan, David H. Jones, Ansgar Brock, et al.. (2014). Site‐Specific Dual Labeling of Proteins by Using Small Orthogonal Tags at Neutral pH. ChemBioChem. 15(12). 1787–1791. 8 indexed citations
8.
Hunt, James, Anthony H. Keeble, Robert E. Dale, et al.. (2012). A Fluorescent Biosensor Reveals Conformational Changes in Human Immunoglobulin E Fc. Journal of Biological Chemistry. 287(21). 17459–17470. 42 indexed citations
9.
Holdom, M.D., Anna M. Davies, Joanne E. Nettleship, et al.. (2011). Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI. Nature Structural & Molecular Biology. 18(5). 571–576. 102 indexed citations
10.
Karagiannis, Panagiotis, Josef Singer, James Hunt, et al.. (2008). Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. Cancer Immunology Immunotherapy. 58(6). 915–930. 76 indexed citations
11.
Hunt, James, Marguerite Bracher, Jianguo Shi, et al.. (2008). Attenuation of IgE Affinity for FcϵRI Radically Reduces the Allergic Response in Vitro and in Vivo. Journal of Biological Chemistry. 283(44). 29882–29887. 11 indexed citations
12.
Karagiannis, Sophia N., Marguerite Bracher, James Hunt, et al.. (2007). IgE-Antibody-Dependent Immunotherapy of Solid Tumors: Cytotoxic and Phagocytic Mechanisms of Eradication of Ovarian Cancer Cells. The Journal of Immunology. 179(5). 2832–2843. 74 indexed citations
13.
Karagiannis, Sophia N., Marguerite Bracher, Rebecca L. Beavil, et al.. (2007). Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunology Immunotherapy. 57(2). 247–263. 48 indexed citations
14.
McCloskey, Natalie, James Hunt, Rebecca L. Beavil, et al.. (2007). Soluble CD23 Monomers Inhibit and Oligomers Stimulate IGE Synthesis in Human B Cells. Journal of Biological Chemistry. 282(33). 24083–24091. 63 indexed citations
15.
Prag, Søren, Maddy Parsons, Matthias Epple, et al.. (2007). Activated Ezrin Promotes Cell Migration through Recruitment of the GEF Dbl to Lipid Rafts and Preferential Downstream Activation of Cdc42. Molecular Biology of the Cell. 18(8). 2935–2948. 81 indexed citations
16.
Parsons, Maddy, Ian Kirby, Andrew J. Beavil, et al.. (2006). Analysis of the interaction between RGD-expressing adenovirus type 5 fiber knob domains and αvβ3 integrin reveals distinct binding profiles and intracellular trafficking. Journal of General Virology. 87(9). 2497–2505. 16 indexed citations
17.
Hunt, James, Rebecca L. Beavil, Rosaleen A. Calvert, et al.. (2005). Disulfide Linkage Controls the Affinity and Stoichiometry of IgE Fcϵ3–4 Binding to FcϵRI. Journal of Biological Chemistry. 280(17). 16808–16814. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026